Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Perspectives on Maxeon Solar Technologies A Shift Towards Negativity

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
Renewable energy
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Analysts have recently shared a variety of perspectives on Maxeon Solar Technologies, ranging from optimistic to pessimistic. Over the past three months, there have been a total of 4 analyst ratings, including 1 bullish, 2 neutral, and 1 bearish. The average 12-month price target for Maxeon Solar Technologies stands at $7.25, with a high estimate of $11.00 and a low estimate of $3.00. Analyst actions have contributed to a 27.5% decrease in the average price target, indicating a shift towards a more negative sentiment.

Recent evaluations by key analysts such as William Grippin from UBS, Maheep Mandloi from Mizuho, and Brian Lee from Goldman Sachs have influenced the market sentiment. Grippin lowered the rating to Sell with a price target of $3.00, while Mandloi adjusted the rating to Neutral with price targets of $7.00 and $8.00. Lee, on the other hand, lowered the rating to Buy with a price target of $11.00.

Analysts frequently update their recommendations based on market conditions and company performance, reflecting their reactions to recent developments concerning Maxeon Solar Technologies. These shifts in ratings and price targets offer valuable insights into analysts’ perceptions of the company’s current standing.

MAXN Stock Plunges 6.63% on March 8, 2024: What Investors Need to Know

MAXN stock had a rough day on March 8, 2024, as it traded near the bottom of its 52-week range and below its 200-day simple moving average. The price of MAXN shares decreased by $0.27, representing a significant 6.63% drop since the market last closed. The stock opened at $3.76, $0.24 lower than its previous close.

Investors may be cautious about MAXN’s prospects in the near term, as the stock’s performance on March 8 reflects a lack of confidence in its ability to deliver positive returns. The drop in price could also be a result of negative news or developments related to the company.

It is important for investors to carefully monitor MAXN’s performance and consider the factors driving its stock price movement. While short-term fluctuations are common in the stock market, a sustained downward trend could signal underlying issues that may impact the company’s long-term growth potential.

MAXN Stock Reports Mixed Performance: Revenue Up, Net Loss Down

MAXN stock had a mixed performance on March 8, 2024, as the company reported its financial results for the past year and the third quarter. According to data from CNN Money, MAXN’s total revenue for the past year was $1.06 billion, showing a significant increase of 35.34% compared to the previous year. However, the total revenue for the third quarter was $227.63 million, which represented a decrease of 34.66% compared to the previous quarter.

In terms of net income, MAXN reported a net loss of $267.42 million for the past year, which was a decrease of 5.07% compared to the previous year. The net loss for the third quarter was $108.26 million, showing a significant decrease of 7074.09% compared to the previous quarter.

Earnings per share (EPS) also showed a mixed performance for MAXN. The EPS for the past year was -$6.54, which represented a 3.82% increase compared to the previous year. However, the EPS for the third quarter was -$2.21, showing a significant decrease of 6524.85% compared to the previous quarter.

Tags: MAXN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
COST stock news

Analysts Provide Mixed Views on Marvell Technology Incs Performance

Renewable energy

Analyzing Short Interest in SolarEdge Technologies and Its Industry Peers

Consumer Electronics Stock Market Today

The Power of Investing in Amphenol A Decade of Growth and Profitability

Recommended

Eli Lilly Stock

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

3 months ago
Applovin Stock

Regulatory Storm Clouds Gather Over Applovin

4 months ago
Apple Stock

Berkshire’s Apple Share Sale Sparks Market Speculation Ahead of Key Launch

5 months ago
Asml Stock

Is ASML Stock Presenting a Major Buying Opportunity?

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Trending

ServiceNow Stock
AI & Quantum Computing

ServiceNow Shares Face Market Skepticism Despite Record Performance

by Jackson Burston
February 7, 2026
0

In late January 2026, ServiceNow reported quarterly financial results that surpassed even the most optimistic projections from...

Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026
CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • ServiceNow Shares Face Market Skepticism Despite Record Performance
  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com